ADMA Biologics SG&A Expense (Quarterly) Trends

ADMA Biologics Inc (ADMA)

6.65 +0.13 (+1.99%) USD | NASDAQ | May 01, 16:00

6.65 0.00 (0.00%) After-Hours: 16:23

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2009. Upgrade now.

Date	Value
December 31, 2023	15.54M
September 30, 2023	14.73M
June 30, 2023	14.25M
March 31, 2023	14.51M
December 31, 2022	13.89M
September 30, 2022	12.89M
June 30, 2022	11.97M
March 31, 2022	13.70M
December 31, 2021	11.70M
September 30, 2021	10.73M
June 30, 2021	10.44M
March 31, 2021	10.03M
December 31, 2020	9.300M
September 30, 2020	9.116M
June 30, 2020	8.703M
March 31, 2020	7.932M
December 31, 2019	7.032M
September 30, 2019	7.197M
June 30, 2019	6.086M
March 31, 2019	5.596M
December 31, 2018	6.073M
September 30, 2018	5.670M
June 30, 2018	5.438M
March 31, 2018	5.321M
December 31, 2017	5.844M

Date	Value
September 30, 2017	4.196M
June 30, 2017	4.436M
March 31, 2017	4.277M
December 31, 2016	3.284M
September 30, 2016	1.779M
June 30, 2016	1.724M
March 31, 2016	1.708M
December 31, 2015	1.884M
September 30, 2015	2.078M
June 30, 2015	1.437M
March 31, 2015	1.346M
December 31, 2014	1.112M
September 30, 2014	1.035M
June 30, 2014	1.542M
March 31, 2014	1.135M
December 31, 2013	0.9986M
September 30, 2013	0.8453M
June 30, 2013	1.090M
March 31, 2013	1.431M
December 31, 2012	0.6962M
September 30, 2012	1.034M
June 30, 2012	0.7369M
March 31, 2012	0.6746M
December 31, 2011	0.0039M
September 30, 2011	0.0039M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

6.086M

Minimum

Jun 2019

15.54M

Maximum

Dec 2023

11.04M

Average

10.73M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks